Zhou T, Qin S, Xu W, Tang S, et al. Proxalutamide in metastatic castration-resistant prostate cancer: primary analysis of a multicenter, randomized, open-label, phase 2 trial. Int J Cancer 2023 Mar 15. doi: 10.1002/ijc.34512.
PMID: 36919366